“rana-therapeutics” Archives

in
Entry Author Date Location
Dyne Therapeutics Emerges With $50M to Take On Rare Muscle Disease 04/03/19 Boston
FDA Places Clinical Hold on Translate Bio’s mRNA Drug Study 01/22/19 Boston
Neon Therapeutics, Translate Bio Join the Ranks of IPO Hopefuls 06/04/18 Boston
Eli Lilly to Pursue mRNA Cancer Vaccines with CureVac Pact 10/18/17 Indiana
Bio Roundup: Senate Drama, A.I. Stories, Data Dives, Shkreli & More 06/30/17 National
At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills 02/27/17 Boston
RaNA Therapeutics Receives $50,999,987 New Financing Round 01/06/17 Boston
RaNA Expands, Joins Messenger RNA Drug Race With Shire Deal 01/04/17 Boston
Ex-Epizyme CEO’s New Startup, Fulcrum, Nabs $55M For Gene Control Drugs 07/19/16 Boston
Moving on From Sarepta, Krieg Lands at Cancer Startup Checkmate Pharma 08/12/15 Boston
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
RaNA CEO Renaud Turns To A Former Backer To Lead $55M Series B 07/23/15 Boston
RaNA Therapeutics Receives $55,000,000 Series B Funding Round 07/23/15 Boston
East Coast Biotech Roundup: Unum, RaNA, Maxwell, Biogen, & More 12/05/14 Boston
After Unlikely Idenix Sale, Renaud Jumps to RaNA to Outfox Junk DNA 12/01/14 Boston
East Coast Biotech Roundup: JP Morgan Edition 01/17/14 Boston
What Biotech Pros Will Be Chirping About at JP Morgan This Week 01/13/14 National
Forma, CRT Deal Part of Broader Research Initiative 07/09/13 Boston
The Few and the Proud: The Biotech Startup Class of 2012 11/26/12 National
Corporate VC Investing Drops in Q1, Mobile Funding Poised to Jump 06/28/12 National
RaNA Raises $20.7M From Atlas, SR One, Monsanto, for RNA-Based Tech 01/18/12 Boston
RaNA Therapeutics Receives $20,700,000 Series A Funding 01/18/12 Boston
RaNA Therapeutics Secures $2,660,000 New Round 12/02/11 Boston
Page 1 of 1